Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Downey

Showing results (51-60 of 520) with videos related to

Pageof 52
Sort By:
Circulation|April 26, 2017
Letter by Downey and Cohen Regarding Article, "Protective Effects of Ticagrelor on Myocardial Injury After Infarction"James M Downey, Michael V Cohen
Physiological Reviews|September 25, 2003
Preconditioning the myocardium: from cellular physiology to clinical cardiologyDerek M Yellon, James M Downey
Basic Research in Cardiology|November 14, 2007
Adenosine: trigger and mediator of cardioprotectionMichael V Cohen, James M Downey
Circulation|September 19, 2007
Bypassing big pharmaJames M Downey, Michael V Cohen
Journal of Molecular and Cellular Cardiology|March 29, 2001
Mitochondrial K(ATP)channel opening during index ischemia and following myocardial reperfusion in ischemic rat heartsJ M Downey, M V Cohen
Journal of the American College of Cardiology|March 21, 2006
AMISTAD trials: possible reasons for lack of successMichael V Cohen, James M Downey
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1975
The transmural distribution of coronary blood flow during maximal vasodilationJ M Downey, E S Kirk
Cardiovascular Research|June 10, 2008
Oestrogen plays a permissive role in cardioprotectionMichael V Cohen, James M Downey
The American Journal of the Medical Sciences|February 11, 2017
Manuscript Development and Publishing: A 5-Step ApproachSusan M Downey, Stephen A Geraci
Cardiovascular Research|March 1, 2015
Status of P2Y12 treatment must be considered in evaluation of myocardial ischaemia/reperfusion injuryMichael V Cohen, James M Downey
Pageof 52

Showing results (51-60 of 520) with videos related to

Sort By:
Pageof 52
Circulation|April 26, 2017
Letter by Downey and Cohen Regarding Article, "Protective Effects of Ticagrelor on Myocardial Injury After Infarction"James M Downey, Michael V Cohen
Physiological Reviews|September 25, 2003
Preconditioning the myocardium: from cellular physiology to clinical cardiologyDerek M Yellon, James M Downey
Basic Research in Cardiology|November 14, 2007
Adenosine: trigger and mediator of cardioprotectionMichael V Cohen, James M Downey
Circulation|September 19, 2007
Bypassing big pharmaJames M Downey, Michael V Cohen
Journal of Molecular and Cellular Cardiology|March 29, 2001
Mitochondrial K(ATP)channel opening during index ischemia and following myocardial reperfusion in ischemic rat heartsJ M Downey, M V Cohen
Journal of the American College of Cardiology|March 21, 2006
AMISTAD trials: possible reasons for lack of successMichael V Cohen, James M Downey
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1975
The transmural distribution of coronary blood flow during maximal vasodilationJ M Downey, E S Kirk
Cardiovascular Research|June 10, 2008
Oestrogen plays a permissive role in cardioprotectionMichael V Cohen, James M Downey
The American Journal of the Medical Sciences|February 11, 2017
Manuscript Development and Publishing: A 5-Step ApproachSusan M Downey, Stephen A Geraci
Cardiovascular Research|March 1, 2015
Status of P2Y12 treatment must be considered in evaluation of myocardial ischaemia/reperfusion injuryMichael V Cohen, James M Downey
Pageof 52